Buscar
Mostrando ítems 1-10 de 131
Women's preferences for vaginal antimicrobial contraceptives. V: Attitudes of Brazilian women to the insertion of vaginal products
(Elsevier Science IncNew YorkEUA, 2003)
Recent advances in hydrogels as strategy for drug delivery intended to vaginal infections
(2020-11-30)
Vaginal infections represent a clear women health problem due to the several issues as high recurrence rate, drug resistence and emergence of persistent strains. However, achieving improvements in therapeutic efficacy by ...
Formulation, stability study and preclinical evaluation of a vaginal cream containing curcumin in a rat model of vulvovaginal candidiasis
(Wiley-Blackwell, 2018-10-01)
Owing to the growing resistance among isolates of Candida species to usual antifungal agents and the well-known therapeutic potential of curcumin, the purpose of this study was to develop and validate a vaginal formulation ...
Encapsulation and subsequent freeze-drying of Lactobacillus reuteri CRL 1324 for its potential inclusion in vaginal probiotic formulations
(Elsevier Science, 2015-08-21)
Probiotic formulations must include a high number of viable and active microorganisms. In this work, the survival of human vaginal Lactobacillus reuteri CRL 1324 during encapsulation, lyophilization and storage, and the ...
First steps towards the pharmaceutical development of ovules containing Lactobacillus Strains: Viability and antimicrobial activity as basic first parameters in vaginal formulations
(Springer, 2018-02)
In the majority of Latin-American countries, including Argentina, there is a limited availability of vaginal bioproducts containing probiotics in the market. In addition, the conventional treatments of genital tract ...
Women's preferences for vaginal antimicrobial contraceptives I - Methodology
(Elsevier Science IncNew YorkEUA, 1998)
Mucoadhesive In Situ Gelling Liquid Crystalline Precursor System to Improve the Vaginal Administration of Drugs
(2019-08-01)
The vaginal mucosa is a very promising route for drug administration due to its high permeability and the possibility to bypass first pass metabolism; however, current vaginal dosage forms present low retention times due ...
Women's preferences for vaginal antimicrobial contraceptives IV - Attributes of a formulation that would protect from STD/AIDS
(Elsevier Science IncNew YorkEUA, 1998)
Women's preferences for vaginal antimicrobial contraceptives II - Preferred characteristics according to women's age and socioeconomic status
(Elsevier Science IncNew YorkEUA, 1998)